Register entry
Verity Pharmaceuticals Inc.
- Registered sites
- 0
- Drug products
- 4
- Live patents
- 15
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
15Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| TLANDO | TESTOSTERONE UNDECANOATE | Jan 2029 |
| TLANDO | TESTOSTERONE UNDECANOATE | Nov 2030 |
| TLANDO | TESTOSTERONE UNDECANOATE | Nov 2037 |
| TLANDO | TESTOSTERONE UNDECANOATE | Feb 2039 |
| TLANDO | TESTOSTERONE UNDECANOATE | Oct 2040 |
| TLANDO | TESTOSTERONE UNDECANOATE | Apr 2041 |
| TRELSTAR | TRIPTORELIN PAMOATE | Jun 2029 |
Catalogue
Marketed products
4Showing 4 of 4.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Tlando | testosterone undecanoate | CAPSULE, LIQUID FILLED | NDA |
| Trelstar | triptorelin pamoate | KIT | NDA |
| Trelstar | triptorelin pamoate | KIT | NDA |
| Trelstar | triptorelin pamoate | KIT | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.